Interleukin-2: Clinical applications

Atkins, Michael B.·2002·Seminars in Oncology
DOI 10.1053/sonc.2002.33077

Cited by (156)

Items 101–156 of 156

  1. Prognostic and Diagnostic Significance of Chemokines and Cytokines in Cancer
    Manzoor Ahmad Mir, Aanisa Ishrat, Nusrat Jan · 2023 · Springer eBooks
  2. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy
    Karen Cristina Barbosa Chaves, Lauro Thiago Turaça, João Bosco Pesquero, Grégory Mennecier, M.L. Dagli, Roger J. Chammas, Nestor Schor, Maria Helena Bellini · 2012 · Biomedicine & Pharmacotherapy
  3. The Grand Challenge for the Future
    Kaufmann, Stefan H.E, Lambert, Paul-Henri · 2005 · Birkhäuser Basel eBooks
  4. Emerging cancer-targeted therapies
    Robert John Arceci, Timothy P. Cripe · 2002 · Pediatric Clinics of North America
  5. Low-Dose IL-2 as a Therapeutic Agent for Tolerance Induction
    Thomas R. Malek, Alberto Pugliese · 2011 · Immunotherapy
  6. Engineering Of Therapeutic Proteins
    Huimin Zhao, Sheryl B. Rubin-Pitel, Fei Wen · 2009 · CRC Press eBooks
  7. Human genetic therapy
    Jonathan M. Harris, Karol Sikora · 1993 · Molecular Aspects of Medicine
  8. Nursing management of patients receiving biological therapy
    S. Kate Sandstrom · 1996 · Seminars in Oncology Nursing
  9. Peripheral nerve entrapment: An unusual adverse event with high-dose interleukin-2 therapy
    Sadiq Saleem Sikora, M.E. Samsonov, K.A. Dookeran, Howard D. J. Edington, Michael T. Lotze · 1996 · Annals of Oncology
  10. Cytokines in the Treatment of Cancer
    Kim Allyson Margolin, Mark N. Lazarus, Howard L. Kaufman · 2012 · Springer eBooks
  11. Interleukin‐2: From T Cell Growth and Homeostasis to Immune Reconstitution of HIV Patients
    Marko Kryworuchko, Jacques Thèze · 2006 · Vitamins and hormones
  12. The role of biological response modifiers in malignant melanoma
    Marko B. Lens · 2003 · Expert Opinion on Biological Therapy
  13. Mathematical model for IL-2-based cancer immunotherapy
    Megan Dixon, Tuan Anh Phan, J. C. Dallon, Jianjun Paul Tian · 2024 · Mathematical Biosciences
  14. Interleukins: The search for an anticancer therapy
    Vera S. Wheeler · 1996 · Seminars in Oncology Nursing
  15. Intracellular Flow Cytometry Improvements in Clinical Studies
    Julie Demaret, Morgane Gossez, Fabienne Venet, Guillaume Monneret · 2016 · Methods in molecular biology
  16. Hematopoietic Growth Factors and Cytokines
    Sühendan Ekmekçioglu, Razelle Kurzrock, Elizabeth Ann Grimm · 2008 · Elsevier eBooks
  17. Design and selection of vaccine adjuvants: principles and practice
    Carl R. Alving, Gary R. Matyas · 2005 · Birkhäuser-Verlag eBooks
  18. General Principles of Tumor Immunotherapy
    Howard L. Kaufman, Jedd D. Wolchok · 2007 · Springer eBooks
  19. Drug and Radiation Toxicity
    Anthony A. Gal · 2008 · Springer eBooks
  20. Interleukin-2 Abolishes Myeloid Cell Accumulation Induced by Lewis Lung Carcinoma
    Masaharu Shin‐Ya, Osam Mazda, Chiharu Tsuchihara, Hideyo Hirai, Jirô Imanishi, Minoru Takeuchi · 2003 · Journal of Interferon & Cytokine Research
  21. Immunotherapy in liver tumors: III. A new experimental model of metastatic liver tumors from colorectal carcinoma for cytokine therapy
    David L. Liu, M Radnell, Katarina Svanberg, J. Seifert · 1995 · Cancer Letters
  22. New Standards in the Treatment of Advanced Metastatic Melanoma: Immunotherapy and BRAF-Targeted Therapies as Emerging Paradigms
    Firas Kreidieh, Michael K. Wong · 2025 · Current Pharmaceutical Design
  23. Immunotherapy in liver tumours: I. Combined administration of recombinant interleukin-2 (IL-2) and interferon-α through the subcutaneous transposed spleen prolongs the half-life of IL-2 in vivo and enhances antitumor effects
    David L. Liu, J. Seifert, Wojciech B. Cwikiel · 1994 · Cancer Letters
  24. One step purification of biological active human interleukin-2 protein produced in yeast (Pichia Pastoris)
    Ahmed · 2011 · AFRICAN JOURNAL OF BIOTECHNOLOGY
  25. Avances en inmunoterapia celular contra el melanoma maligno
    Mercedes Natalia López, Alejandro F. Escobar, Jorge Alfaro L, M Fodor, Milton L. Larrondo, Carlos Ferrada V, Flavio Salazar‐Onfray · 2004 · Revista médica de Chile
  26. Does Phytosterol Intake Affect The Development Of Cancer?
    Lena Norm√©n, Susan W. Andersson · 2003 · Nutraceutical science and technology
  27. HSH2D contributes to methotrexate resistance in�human T‑cell acute lymphoblastic leukaemia
    Jing Wang, Yiying Xiong · 2020 · Oncology Reports
  28. Cytokines and Chemokines
    Oliver A. Perez, Brian Berman · 2008 · Springer eBooks
  29. Renin Angiotensin System (Ras) Blockade Attenuates Growth and Metastasis Formation of Renal Cell Carcinoma in Mice
    Wedson F. Araújo, Marcelo Andery Naves, Juliana Naves Ravanini, Valdirene Dias Campos Teixeira · 2014 · Annals of Oncology
  30. Immune Response Modulators in the Treatment of Skin Cancer
    Brian Berman, Martha H. Viera, Sadegh Amini, Whitney Valins · 2011 · Elsevier eBooks
  31. Hematopoietic Growth Factors and Cytokines
    Sühendan Ekmekçioglu, Razelle Kurzrock, Elizabeth Ann Grimm · 2015 · Elsevier eBooks
  32. Report on the ISBTC Mini-symposium on Biologic Effects of Targeted Therapeutics
    Michael B. Atkins, David Carbone, George Coukos, Madhav V. Dhodapkar, Marc S. Ernstoff, James Harold Finke, Thomas Frank Gajewski, Jared Gollob, Michael T. Lotze, Walter J. Storkus et al. · 2007 · Journal of Immunotherapy
  33. The Biology of Cytokines
    Davide Agnello, Massimo Gadina · 2006 · CRC Press eBooks
  34. Hypercalcemia, Hypocalcemia, and Other Divalent Cation Disorders
    Pouneh Nouri, Francisco Llach · 2008 · Elsevier eBooks
  35. Interleukin-2
    Hironobu Asao · 2004 · Elsevier eBooks
  36. Regulating IL-2 Immune Signaling Function Via A Core Allosteric Structural Network
    Claire H. Woodward, Shahlo O. Solieva, Daniel H. Hwang, Viviane S. De Paula, Charina S. Fabilane, Michael C. Young, Tony Trent, Ella C. Teeley, Ananya K. Majumdar, Jamie B. Spangler et al. · 2024 · Journal of Molecular Biology
  37. A case of profound hypercalcaemia and acute kidney injury
    Habibur Rahman, Peter J. Dupont, Marc C. Cohen, Rama Vancheeswaran · 2013 · BMJ
  38. Obtaining Routine Blood Cultures During Interleukin-2-Containing Therapy Is Unnecessary
    Michael Vishal Jaglal, Damian A. Laber, Forest Wayne Arnold, Donald Max Miller, Jason Alan Chesney, Goetz Hans Kloecker · 2009 · American Journal of Clinical Oncology
  39. Protein Therapeutics in Oncology
    Michael J. Corbley · 2011 · Springer eBooks
  40. High-Dose Interleukin-2: Evaluation of a Standardized Order Set for Biotherapy in an Intensive Care Unit
    Rusticio Portillas, Barbara Swope Turner, Audrey Jeffers, Lee‐lynn Chen, Mary T. Champagne · 2017 · Clinical journal of oncology nursing
  41. Expression of the IL-2R in Human Podocytes and the Effect of Activation on Autophagy and Apoptosis
    Tyrus Stewart, Arnold H. Zea, Diego Avilés · 2020 · Fetal and Pediatric Pathology
  42. Cutaneous Melanoma
    Mark R. Albertini, B. Jack Longley, Paul M. Harari, Douglas S. Reintgen · 2007 · Springer eBooks
  43. Interleukin-2 in Metastatic Renal Cell Carcinoma
    Thomas E. Olencki, Ronald M. Bukowski · 2000 · Humana Press eBooks
  44. SYNERGY BETWEEN JAK INHIBITOR RUXOLITINIB AND TYROSINE KINASE INHIBITORS TO OVERCOME DRUG RESISTANCE RELATED TO BONE MARROW STROMA MICROENVIRONMENT IN CHRONIC MYELOID LEUKEMIA
    Biagio De Angelis · 2013
  45. Principles of Chemotherapy
    Rowena N Schwartz, Tiffany V. Goolsby, Wells A. Messersmith · 2008 · Cambridge University Press eBooks
  46. Mise au point de thérapies anti-tumorales impliquant des vecteurs parvoviraux et la fusion de cellules tumorales et dendritiques
    Charlotte Servais, Thierry J. Velu, Annick Brandenburger · 2007 · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
  47. A Case of Renal Cell Carcinoma with Bone and Lymph Node Metastases
    Marisa Di Seri, Attilio Verì, Maria Luisa Colloca, Bruno Spalletta, Rosalinda Rossi, Pia Pierpaola Petrella, Deborah Coletta, Fausto Petricola, Serena Ricciardi, Luigi Frati · 2003 · Tumori Journal
  48. Histamine’s vasoactive properties improving response rates in solid tumor treatment
    Flávia Brunstein · 2006 · RePub (Erasmus University Rotterdam)
  49. IN VITRO BOOSTING AND EXPANSION OF TUMOR INFILTRATING KILLER T CELLS
    Chunlei Mei · 2010 · TigerPrints (Clemson University)
  50. Immunomodulatory Molecules of the Immune System
    Yvonne M. Saenger, Robert R. Jenq, Miguel‐Angel Perales · 2007 · Springer eBooks
  51. Adjuvants, Dendritic Cells, and Cytokines: Strategies for Enhancing Vaccine Efficacy
    Paola Rizza, Imerio Capone, Filippo Belardelli · 2007 · Springer eBooks
  52. SA-4-1BBL as a modulator of innate, adaptive, and regulatory immunity : implications for cancer prevention and treatment.
    Hampartsoum B. Barsoumian · 2016
  53. Moduladores inmunitarios en el tratamiento del cáncer de piel
    Brian Berman · 2006 · Elsevier eBooks
  54. Recent Advances in Glycoprotein Synthesis: A Refined Synthetic Probe towards the Biological World
    Haoru Zhuang, Yongshun Qiu, Huiran Hao, Jinjuan Gan, Tianlu Li · 2023
  55. Développement d'une "biopuce à cellules" pour l'analyse des sécrétions de cytokines par les lymphocytes T individuels
    Dieudonné R. Baganizi · 2014
  56. The epigenetic regulation of chemotherapy resistance in melanoma
    Hussein Abdul-Hassan Tawbi · 2011 · D-Scholarship@Pitt (University of Pittsburgh)